During the past decade, SAM Clinical Research Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 13 clinical trials were completed, i.e. on average, 260% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SAM Clinical Research Center" #1 sponsor was "AstraZeneca" with 12 trials, followed by "Mannkind Corporation" with 6 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SAM Clinical Research Center" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "SAM Clinical Research Center" are "Diabetes Mellitus, Type 2" (5 trials), "Type 2 Diabetes" (5 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (3 trials), "Type 2 Diabetes Mellitus" (3 trials) and "Diabetes" (2 trials). Many other conditions were trialed in "SAM Clinical Research Center" in a lesser frequency.

Most popular intervention types in "SAM Clinical Research Center" are "Drug" (30 trials), "Biological" (2 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "AC2993" (4 trials), "Dapagliflozin" (4 trials), "Metformin" (4 trials) and "Saxagliptin" (4 trials). Other intervention names were less common.

The vast majority of trials in "SAM Clinical Research Center" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "SAM Clinical Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in SAM Clinical Research Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in SAM Clinical Research Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".